Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 1191995-00-2
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
1191995-00-2 |
Appearance :: |
Solid |
Molecular Formula:: |
C22H27ClN4O5 |
Molecular Weight:: |
462.927 |
EINECS NO:: |
N/A |
MDL NO:: |
N/A |
CAS NO:: |
1191995-00-2 |
Appearance :: |
Solid |
Molecular Formula:: |
C22H27ClN4O5 |
Molecular Weight:: |
462.927 |
EINECS NO:: |
N/A |
MDL NO:: |
N/A |
Product Description
Product Name: dorzagliatin CAS NO:1191995-00-2
Synonyms:
(S)-2-[4-(2-chloro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-((R)-2,3-dihydroxy-propyl)-1H-pyrazol-3-yl]-amide;
Chemical & Physical Properties
Appearance : Solid
Assay : ≥98.0%
Density:1.4g/cm3
Boiling Point: 761.7°C at 760 mmHg
Flash Point:414.5℃
Dorzagliatin, also known as HMS 5552, RO5305552 and sinogliatin, is a novel Dual-Acting Glucokinase Activator, which Improves Glycaemic Control and Pancreatic β-Cell Function in Patients With Type 2 Diabetes. By addressing the defect of the glucose sensor function of glucokinase, dorzagliatin has the potential to restore the impaired glucose homeostasis state of people with type 2 diabetes and serve as a first-line standard-of-care therapy for the treatment of the disease, or as a cornerstone therapy when taken in combination with currently approved anti-diabetes drugs.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
